Medicine Description trexozola 2.5mg
trexozola 2.5mg tablets is a medication that functions as an aromatase inhibitor, primarily utilized in the management of hormone receptor-positive breast cancer. It operates by hindering the aromatase enzyme, which plays a pivotal role in converting androgens into estrogens in postmenopausal women. By reducing estrogen levels in the body, trexozola diminishes the stimulus for estrogen-dependent tumors, thus slowing their growth and proliferation. This mechanism is particularly effective because many breast cancers rely on estrogen for their growth, allowing trexozola to play a crucial role in the therapeutic strategy against this malignancy.
Indications and Uses of trexozola 2.5mg tablets
- Adjuvant treatment of hormone receptor-positive breast cancer in postmenopausal women
- Treatment of advanced breast cancer in postmenopausal women following disease progression on tamoxifen therapy
Side Effects of trexozola 2.5mg tablets
- Hot flashes
- Joint pain or stiffness
- Fatigue
- Nausea
- Headaches
- Increased sweating
- Bone density loss
Storage and Handling
Store trexozola 2.5mg tablets at room temperature, away from moisture and direct sunlight. Keep out of reach of children and dispose of any unused medication responsibly.
Patient Advice and Precautions
Patients should be counselled to maintain regular follow-up appointments for monitoring treatment response and side effects. It is crucial to inform healthcare providers about any existing medical conditions or concurrent medications. Patients experiencing severe side effects should seek medical advice promptly. Lifestyle modifications, such as maintaining a healthy diet and engaging in regular physical activity, may also enhance overall well-being during treatment.